Hepatocellular Carcinoma and Pancreatic Cancer | Kim A Reiss Binder, MD

Consensus or Controversy? Clinical Investigator Perspectives on the Current and Future Management of Hepatocellular Carcinoma and Pancreatic Cancer — Faculty Presentation 2: Considerations in the Use of PARP Inhibitors in Pancreatic Cancer — Dr Reiss Binder CME information and select publications